Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 31,820 | 30,613 | 32,567 | 41,525 | 37,762 |
| Operating Income | -31,820 | -30,613 | -32,567 | -41,525 | -37,762 |
| Interest Expense | 406 | 427 | 446 | 429 | 427 |
| Other Income | 1,472 | 1,877 | 2,306 | 2,555 | 2,608 |
| Pre-tax Income | -30,754 | -29,163 | -30,707 | -39,399 | -35,581 |
| Net Income Continuous | -30,754 | -29,163 | -30,707 | -39,399 | -35,581 |
| Net Income | $-30,754 | $-29,163 | $-30,707 | $-39,399 | $-35,581 |
| EPS Basic Total Ops | -0.58 | -0.53 | -0.58 | -0.76 | -0.71 |
| EPS Basic Continuous Ops | -0.58 | -0.53 | -0.58 | -0.76 | -0.71 |
| EPS Diluted Total Ops | -0.58 | -0.53 | -0.58 | -0.76 | -0.71 |
| EPS Diluted Continuous Ops | -0.58 | -0.53 | -0.58 | -0.76 | -0.71 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -0.55 | -0.58 | -0.76 | N/A |
| EBITDA(a) | $-32,068 | $-31,067 | $-33,327 | $-42,556 | $-39,037 |